Search Within

Human Oncology and Pathogenesis Program

Formats
  1. Journal Article (3016)
  2. Meeting Abstract (2565)
  3. Review (137)
  4. Editorial (107)
  5. Book Section (54)
  6. Research Letter (42)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (16)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. GSK Faculty (5769)
  2. Department of Medicine (4320)
  3. Department of Pathology and Laboratory Medicine (3070)
  4. Tow Center for Developmental Oncology (TCDO) (2639)
  5. Solid Tumor Oncology Division (2634)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (2584)

More Groups

People
  1. Marc Ladanyi (1332)
  2. Ross Levine (786)
  3. David Solit (781)
  4. Michael Berger (769)
  5. Nikolaus Schultz (491)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (171)
  2. 2024 (381)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (649)
  2. Blood (517)
  3. Cancer Research (413)
  4. Modern Pathology (300)
  5. Clinical Cancer Research (269)
  6. Laboratory Investigation (265)

More Publications

Publishers
  1. American Association for Cancer Research (876)
  2. Nature Publishing Group (767)
  3. American Society of Clinical Oncology (717)
  4. American Society of Hematology (564)
  5. Elsevier Inc. (420)
  6. Nature Research (314)

More Publishers

Results (5987)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pharmacological therapy of mouse models of thyroid cancer induced by oncogenic effectors in the MAPK and PI3K pathways
    Meeting Abstract

    Fagin, J. A.; Franco, A.; Malaguarnera, R.; Ghossein, R.; Chakravarty, D.; Knauf, J. A.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Amplification of wild-type BRAF in melanoma is associated with activation of RAF-MEK-ERK signaling and MEK-dependence
    Meeting Abstract

    Blumenthal, E.; Poulikakos, P. I.; Tadi, M.; Grbovic-Huezo, O.; Taylor, B. S.; Janakiraman, M.; Leversha, M.; Viale, A.; Solit, D. B.; Rosen, N.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Towards the evolutionary trajectory leading to glioblastoma multiforme
    Meeting Abstract

    Attolini, C. S. O.; Beroukhim, R.; Mellinghoff, I.; Michor, F.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Reflex testing of lung adenocarcinomas for EGFR and KRAS mutations: The initial Memorial Sloan-Kettering Cancer Center (MSKCC) experience
    Meeting Abstract

    Zakowski, M. F.; Ladanyi, M.; Rekhtman, N.; Park, B.; Finley, D.; Azzoli, C.; Kris, M. G.; Rusch, V.; Miller, V.; Riely, G.
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • Donor KIR 3DS1 is associated with less acute GVHD following unrelated allogeneic hematopoietic cell transplantation for hematologic malignancies
    Meeting Abstract

    Venstrom, J. M.; Gooley, T. A.; Spellman, S. R.; Hasan, R. S.; Pring, J. A.; Malkki, M.; Dupont, B.; Petersdordf, E. W.; Hsu, K. C.
    Biology of Blood and Marrow Transplantation (2009)

    Fulltext@MSK | Save
  • Comparison of CISH and FISH for detection of EGFR copy number in lung adenocarcinomas and correlation with EGFR and KRAS mutation status and EGFR immunohistochemistry reactivity
    Meeting Abstract

    Varella, G. M.; Ladanyi, M.; Kris, M. G.; Rekhtman, N.; Hirsch, F.; Miller, V.; Riely, G.; Pao, W.; Zakowski, M. F.
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • Breast tumor cells with PI3K mutation or HER2 amplification are selectively addicted to Akt signaling
    Meeting Abstract

    She, Q. B.; Chandarlapaty, S.; Ye, Q.; Lobo, J.; Haskell, K. M.; Leander, K. R.; DeFeo-Jones, D.; Huber, H. E.; Rosen, N.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Encapsulated thyroid tumors of gollicular cell origin with high grade features (EFHG): A clinico-pathologic and molecular study of 25 cases
    Meeting Abstract

    Rivera, M.; Ricarte-Filho, J.; Patel, S.; Tuttle, R. M.; Shaha, A.; Shah, J.; Fagin, J. A.; Ghossein, R.
    Modern Pathology (2009)

    Fulltext@MSK | Save
  • Molecular characterization of radioactive iodine refractory (RAIR) FDG-PET positive thyroid carcinoma (TC)
    Meeting Abstract

    Ricarte-Filho, J.; Rivera, M.; Tuttle, R. M.; Fagin, J. A.; Ghossein, R.
    Modern Pathology (2009)

    Fulltext@MSK | Save
  • Analysis of EGFR and KRAS mutations in high-grade neuroendocrine carcinomas of the lung
    Meeting Abstract

    Rekhtman, N.; He, M.; Lau, C.; Nafa, K.; Riely, G. J.; Zakowski, M. F.; Ladanyi, M.
    Modern Pathology (2009)

    Fulltext@MSK | Save